97 related articles for article (PubMed ID: 20949451)
21. The FocalPoint System: FocalPoint slide profiler and FocalPoint GS.
Kardos TF
Cancer; 2004 Dec; 102(6):334-9. PubMed ID: 15549692
[No Abstract] [Full Text] [Related]
22. BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears.
Chute DJ; Lim H; Kong CS
Cancer Cytopathol; 2010 Apr; 118(2):68-74. PubMed ID: 20209621
[TBL] [Abstract][Full Text] [Related]
23. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology.
Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
Cancer; 2008 Jun; 114(3):165-70. PubMed ID: 18454462
[TBL] [Abstract][Full Text] [Related]
25. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
Wilbur DC; Parker EM; Foti JA
Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
[TBL] [Abstract][Full Text] [Related]
26. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
27. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
28. Performance and reproducibility of gynecologic cytology interpretation using the FocalPoint system: results of the RODEO Study Team.
Stein MD; Fregnani JH; Scapulatempo C; Mafra A; Campacci N; Longatto-Filho A;
Am J Clin Pathol; 2013 Oct; 140(4):567-71. PubMed ID: 24045555
[TBL] [Abstract][Full Text] [Related]
29. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
30. Rapid pre-screening is more sensitive in liquid-based cytology than in conventional smears.
Dudding N; Renshaw AA; Ellis K
Acta Cytol; 2011; 55(1):54-6. PubMed ID: 21135523
[TBL] [Abstract][Full Text] [Related]
31. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
Deschenes M; Renshaw AA; Auger M
Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
[TBL] [Abstract][Full Text] [Related]
32. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
33. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
[TBL] [Abstract][Full Text] [Related]
34. A validation study of the FocalPoint GS imaging system for gynecologic cytology screening.
Colgan TJ; Bon N; Clipsham S; Gardiner G; Sumner J; Walley V; McLachlin CM
Cancer Cytopathol; 2013 Apr; 121(4):189-96. PubMed ID: 23361915
[TBL] [Abstract][Full Text] [Related]
35. Quality control and automation in cervical cytology.
Kumar N; Jain S
J Indian Med Assoc; 2004 Jul; 102(7):372, 374, 376 pasim. PubMed ID: 15717583
[TBL] [Abstract][Full Text] [Related]
36. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
37. Predicting screening sensitivity from workload in gynecologic cytology: a review.
Renshaw AA; Elsheikh TM
Diagn Cytopathol; 2011 Nov; 39(11):832-6. PubMed ID: 21994194
[TBL] [Abstract][Full Text] [Related]
38. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
39. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
[TBL] [Abstract][Full Text] [Related]
40. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy.
Elsheikh TM; Kirkpatrick JL; Cooper MK; Johnson ML; Hawkins AP; Renshaw AA
Cancer Cytopathol; 2010 Apr; 118(2):75-82. PubMed ID: 20151428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
